Ranizumab and bevacizumab for the treatment of diabetic macular oedema.

AETSA
Record ID 32018000433
Spanish
Original Title: Ranibizumab y bevacizumab en el tratamiento del edema macular diabético
Authors' objectives: To assess the comparative efficacy of intravitreal ranibizumab versus intravitreal bevacizumab in patients with diabetic macular oedema.
Details
Project Status: Completed
Year Published: 2014
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: Spain
MeSH Terms
  • Macular Edema
  • Diabetic Retinopathy
  • Antibodies, Monoclonal
  • Ranibizumab
  • Bevacizumab
  • Cost-Benefit Analysis
Contact
Organisation Name: Andalusian Health Technology Assessment Area
Contact Address: Area de Evaluacion de Tecnologias Sanitarias Sanitarias de Andalucia (AETSA) Avda. Innovación, s/n Edificio Arena 1. Sevilla (Spain) Tel. +34 955 006 309
Contact Name: aetsa.csalud@juntadeandalucia.es
Contact Email: aetsa.csalud@juntadeandalucia.es
Copyright: Andalusian Agency for Health Technology Assessment (AETSA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.